Epidemiology and management of chronic constipation in elderly patients
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Constipation is a common functional gastrointestinal disorder, with prevalence in the general population of approximately 20%. In the elderly population the incidence of constipation is higher compared to the younger population, with elderly females suffering more often from severe constipation. Treatment options for chronic constipation (CC) include stool softeners, fiber supplements, osmotic and stimulant laxatives, and the secretagogues lubiprostone and linaclotide. Understanding the underlying etiology of CC is necessary to determine the most appropriate therapeutic option. Therefore, it is important to distinguish from pelvic floor dysfunction (PFD), slow and normal transit constipation. Evaluation of a patient with CC includes basic blood work, rectal examination, and appropriate testing to evaluate for PFD and slow transit constipation when indicated. Pelvic floor rehabilitation or biofeedback is the treatment of choice for PFD, and its efficacy has been proven in clinical trials. Surgery is rarely indicated in CC and can only be considered in cases of slow transit constipation when PFD has been properly excluded. Other treatment options such as sacral nerve stimulation seem to be helpful in patients with urinary dysfunction. Botulinum toxin injection for PFD cannot be recommended at this time with the available evidence. CC in the elderly is common, and it has a significant impact on quality of life and the use of health care resources. In the elderly, it is imperative to identify the etiology of CC, and treatment should be based on the patient's overall clinical status and capabilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Simplified assessment of segmental colonic transit
Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928 · cited 1×
“ROM studies are inexpensive and are a widely available way to assess colon transit.(66,67) In addition to total marker counts, marker distribution may also be helpful, as proximal retention suggests colonic dys-”
Lembo, A., & Camilleri, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020995 · Cited by 692
A placebo-controlled trial of prucalopride for severe chronic constipation
Camilleri, M., Kerstens, R., Rykx, A., & Vandeplassche, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800670 · Cited by 576 · cited 1×
“Prucalopride, a 5-hydroxytryptamine receptor 4 agent similar to tegaserod, accelerates colonic transit in patients with constipation, and therapeutic trials have demonstrated efficacy for severe constipation.(88,89) Prucalopride for 4 weeks in elderly nursing home residents was safe and well tolerated, with no adverse…”
DROSSMAN, D. A., CHEY, W. D., JOHANSON, J. F., FASS, R., SCOTT, C., PANAS, R., & UENO, R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03881.x · Cited by 399
Attaluri, A., Jackson, M., Valestin, J., & Rao, S. S. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.655 · Cited by 261
How to Assess Regional and Whole Gut Transit Time With Wireless Motility Capsule
Lee, Y. Y., Erdogan, A., & Rao, S. S. C. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.2.265 · Cited by 187 · cited 1×
“tively determine regional and whole gut transit times of the GI tract.(70) A recent study compared the WMC with ROM in”
Influence of age, gender, hormonal status and smoking habits on colonic transit time
Meier, R., BEGLINGER, C., DEDERDING, J. P., MEYER‐WYSS, B., FUMAGALLI, M., ROWEDDER, A., TURBERG, Y., & BRIGNOLI, R. (1995) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.1995.tb00231.x · Cited by 149 · cited 1×
“Research studies have described delayed colonic transit in the elderly, whereas others have described no significant difference in colonic transit between the elderly and younger patients.(39,40) However, although decreased propulsive forces of the colon have been described in the elderly,(41) there are numerous secon…”
Cited by
Chronic constipation: A review of literature
Forootan, M., Bagheri, N., & Darvishi, M. (2018) · Medicine · doi:10.1097/md.0000000000010631 · Cited by 364
Huang, L. S., Kong, C., Gao, R. Y., Yan, X., Yu, H. J., Wen, B., Zhu, Q., Shen, T. Y., Sun, Z. L., & Qin, H. L. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3149-7 · Cited by 42
Constipation and laxative use among people living in nursing homes in 2007 and 2013
Gustafsson, M., Lämås, K., Isaksson, U., Sandman, P.-O., & Lövheim, H. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1054-x · Cited by 35
Silverii, G. A. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15749 · Cited by 33
“On the other hand, constipation is common in the elderly, 122 and it may paradoxically worsen after metformin withdrawal; therefore, the risks and benefits need to be carefully assessed.”
Prevalence and risk factors of constipation and pollakisuria among older home‐care patients
Komiya, H., Umegaki, H., Asai, A., Kanda, S., Maeda, K., Nomura, H., & Kuzuya, M. (2019) · Geriatrics & Gerontology International · doi:10.1111/ggi.13610 · Cited by 21
Metadata
- Authors
- Bouras, E., & Vazquez-Roque, M.
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2015-06
- Volume
- 10
- Pages
- 919
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W1534334793
- Cited by
- 229
- References
- 8
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.